首页   按字顺浏览 期刊浏览 卷期浏览 Antibacterial Therapy of NeurosyphilisLack of Impact of New Therapies
Antibacterial Therapy of NeurosyphilisLack of Impact of New Therapies

 

作者: Latisha Ali,   Karen L. Roos,  

 

期刊: CNS Drugs  (ADIS Available online 2002)
卷期: Volume 16, issue 12  

页码: 799-802

 

ISSN:1172-7047

 

年代: 2002

 

出版商: ADIS

 

关键词: Antibacterials, therapeutic use;Neurosyphilis, treatment;Penicillins, therapeutic use

 

数据来源: ADIS

 

摘要:

Neurosyphilis is caused by the spirocheteTreponema pallidum. These organisms divide slowly, requiring long exposure to antibacterials for treatment success. In order for an antibacterial to be effective in the therapy of neurosyphilis, it must achieve treponemicidal concentrations in the CSF, have a long half-life and be given in a treatment regimen that favours compliance. Penicillin was first introduced for the treatment of syphilis in 1943, and despite interest in the use of amoxicillin, erythromycin, tetracycline, doxycycline, ceftriaxone and azithromycin, penicillin remains the only recommended antibacterial agent for neurosyphilis.

 

点击下载:  PDF (182KB)



返 回